[ET Net News Agency, 1 April 2026] DUALITYBIO-B (09606) rose 10.2% to HK$325.
It hits an intra-day high of HK$325, breaking above the 100-D SMA of HK$319.844, and an intra-day low of HK$302.2. The total shares traded was 656,840, with a value of HK$205.38m. The active buy/sell ratio is 71:29, with net buying turnover of HK$85.71m. BARCLAYS CAPITAL ASIA accounts for greatest net responsive buying turnover of HK$4.2m, with volume weighted average price of HK$312.52. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$18.24m, with volume weighted average price of HK$312.506. The stock has risen a combined 27% over the past 4 consecutive trading days.
Basic Information| Nominal | 325.000 | % Chg | +10.17% |
| High | 325.000 | Low | 302.200 |
| Shares Tr | 656,840 | Turnover | 205.38m |
| 10-D SMA | 282.280 | %H.V | 75.480 |
| 20-D SMA | 290.350 | VWAP | 312.682 |
| 50-D SMA | 313.260 | RSI14 | 59.231 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 71:29, with net buying turnover of HK$85.71m, rising a combined 27% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| DUALITYBIO-B (09606) | 325.00 | +10.17 |
| INNOVENT BIO (01801) | 90.20 | +6.24 |
| KEYMED BIO-B (02162) | 67.00 | +10.38 |
| XTALPI (02228) | 9.57 | +6.22 |
| WUXI XDC (02268) | 61.30 | +5.33 |
| WUXI BIO (02269) | 34.98 | +5.94 |
| WUXI APPTEC (02359) | 123.80 | +5.36 |
| BEONE MEDICINES (06160) | 184.50 | +7.52 |
| AKESO (09926) | 139.50 | +7.14 |
| REMEGEN (09995) | 108.90 | +13.67 |
(ed)
Nominal 
